| Předmět: |
|
| Zdroj: |
Pharma Business Week; 11/14/2023, p1823-1823, 1p |
| Abstrakt: |
Alset Capital Acquisition Corp., a company in the wholesale drugs industry, has filed a U.S. Securities and Exchange Commission (SEC) form called DEFA14A. This form is a formal document or financial statement submitted by publicly-traded companies. The SEC filing contains additional proxy soliciting materials-definitive. The contact information for Alset Capital Acquisition Corp. is provided in the filing. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
